Seed · Energy · Bristol, United Kingdom · Founded 2021 · 11–50 employees
Astral Systems develops compact multistate fusion reactors for medical isotope production using lattice confinement fusion technology validated by NASA. The Bristol-based company has achieved breakthrough performance in fusion reactions, enabling orders of magnitude improvements in compact form factors. They recently secured £4.5M in funding led by Speedinvest and Playfair to commercialize their technology for cancer diagnosis and treatment. The company has already established three commercial fusion facilities and generated over €2.3M in research contract revenue.
No open roles listed right now.